The end of the beginning for Novartis in India
The Madras court hearing the Novartis suit which argues that the Indian patent law runs contrary to the country’s TRIPs oligations has reserved its verdict and not stated when it is likely to hand down the decision. The court has also referred…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.